ライフサイエンスコーパス: anxiolytic

1 -containing GABAA receptors, was shown to be anxiolytic.

2 t is maladaptive, excessive, repetitive, and anxiolytic.

3 activation is positively reinforcing and/or anxiolytic.

4 tect the urocortins, which are thought to be anxiolytic.

5 ng that inhibition of AT1R within the SFO is anxiolytic.

6 beta (ERbeta) agonists have been shown to be anxiolytic.

7 CE STATEMENT Within the BLA, NPY is potently anxiolytic.

8 opportunities to exploit PTP1B inhibitors as anxiolytics.

9 is an urgent need to develop novel and safe anxiolytics.

10 iety or prescriptions for antidepressants or anxiolytics.

11 with 3.6 (95% CI, 3.2-4.1) for sedatives and anxiolytics, 2.9 (95% CI, 2.3-3.5) for stimulants, and 2

12 bition of the cmA as a common denominator of anxiolytic action, with only OXT inducing large-scale co

13 h after injury, while it was devoid of clear anxiolytic actions and did not affect water-maze perform

14 While lack of clear anxiolytic actions may be connected with an enhanced pot

15 ex (IL-PFC) underlies the antidepressant and anxiolytic actions of ketamine.

16 Although NPY has potent anxiolytic actions within the BLA, selective activation

17 tive emotional effects of stress and exerted anxiolytic actions without influencing hypothalamic-pitu

18 zodiazepines have been widely used for their anxiolytic actions.

19 to the ventricles exerted antidepressant and anxiolytic activity along with an increase in hippocampa

20 e either striatal and limbic stereotypies or anxiolytic activity, thus outlining their potential to t

21 tain psychobiotics possess antidepressant or anxiolytic activity.

22 asingly recognized as an antinociceptive and anxiolytic agent, effects which may be mediated via oxyt

23 Accordingly, exposure to buspirone, an anxiolytic agent, significantly suppresses atypical beha

24 this dose shares some effects with existing anxiolytic agents in dampening response to emotional sti

25 a behavioural response like that induced by anxiolytic agents or antidepressants.

26 istent with effects previously observed with anxiolytic agents.

27 tegy as well as responsivity to conventional anxiolytic agents.

28 er ZD7288 into the ACC in vivo produces both anxiolytic and analgesic effects.

29 We found that the anxiolytic and anti-depressant effects of NPS are enhanc

30 Centrally released oxytocin (OXT) has anxiolytic and anti-stress effects.

31 evealed that compounds 7a,c,d,l,m,q,r,w show anxiolytic and antiamnestic activities without the unple

32 RGS6(-/-) mice exhibit spontaneous anxiolytic and antidepressant behavior rapidly and compl

33 Cre:gamma2(f/f) mice mimicked the effects of anxiolytic and antidepressant drugs in a number of behav

34 dicate potential brain sites involved in the anxiolytic and antidepressant effects of exercise.

35 In conclusion, our results demonstrate anxiolytic and antidepressant-like effects of GHRH analo

36 In vivo, both MIA-690 and MR-409 induced anxiolytic and antidepressant-like effects, increased no

37 ial mechanism whereby endocannabinoids exert anxiolytic and antidepressant-like effects.

38 cretion and has potent anorectic, analgesic, anxiolytic and antidepressive-like effects in animal mod

39 ytocin (OXT) has been revealed as a profound anxiolytic and antistress factor of the brain, besides i

40 In emotional responses, DORs exert dual anxiolytic and anxiogenic roles, both of which may have

41 levating brain endocannabinoids (eCBs) share anxiolytic and fear extinction-facilitating properties w

42 as generated substantial interest due to its anxiolytic and fear-attenuating effects in rodents, whil

43 hat future work should control carefully for anxiolytic and gender effects, which could underlie inco

44 he possibility of two opposing circuits, one anxiolytic and one anxiogenic, within the BNST, the rela

45 The neuropeptide oxytocin (OXT) exerts anxiolytic and prosocial effects in the central nervous

46 he roots of Valeriana officinalis used as an anxiolytic and sedative and in the treatment of insomnia

47 Many smokers describe the anxiolytic and stress-reducing effects of nicotine, the

48 ssion), nonocular pain, and medications (eg, anxiolytics and analgesics).

49 l disorders and has been the major target of anxiolytics and antidepressants.

50 ich were originally developed as nonsedating anxiolytics and cognition enhancers, respectively.

51 anti-inflammatories, cardiovascular agents, anxiolytics and human indicators) in seafood samples.

52 oid psychotropics, including antidepressants/anxiolytics and sleep aids) in the 90 days postdiagnosis

53 es such as diazepam are widely prescribed as anxiolytics and sleep aids.

54 sants, benzodiazepines, or nonbenzodiazepine anxiolytics), and baseline cognitive scores.

55 prophylactic, antigenotoxic, antidepressive, anxiolytic, and anti-amnesic effects.

56 ceptors (GABA(A)Rs) with in vivo anesthetic, anxiolytic, and anti-convulsant effects.

57 bitors in rodent models result in analgesic, anxiolytic, and antiinflammatory phenotypes.

58 D) are nowadays addressed by antidepressant, anxiolytic, and antipsychotic drugs, often administered

59 tility and appetite, and produce anticancer, anxiolytic, and neuroprotective efficacies via cannabino

60 e pharmaceuticals (i.e., antischizophrenics, anxiolytics, and antidepressants) in sludge from 40 repr

61 ombination, antipsychotics, antidepressants, anxiolytics, and hypnotics.

62 ceived prescriptions for antidepressants and anxiolytics, and more than six times as likely to have b

63 ions for benzodiazepines, Z-drugs, and other anxiolytics, and patients were followed for incident dem

64 mitant co-administration of antidepressants, anxiolytics, and psychological therapies.

65 antipsychotics, lithium salts, sedatives and anxiolytics, and stimulants.

66 Both testosterone and estradiol exhibit anxiolytic- and antidepressant-like effects in gonadecto

67 Similarly, voluntary wheel running produces anxiolytic- and antidepressant-like effects in rodent mo

68 R subunit in the amygdala all induced robust anxiolytic- and antidepressant-like effects in several m

69 le for estradiol in mediating the protective anxiolytic- and antidepressant-like effects of testoster

70 estradiol pellet, and subsequent protective anxiolytic- and antidepressant-like effects of testoster

71 Enhancing endocannabinoid signaling produces anxiolytic- and antidepressant-like effects, but the neu

72 rotonergic neurotransmission while promoting anxiolytic- and antidepressant-like effects.

73 Repeated ketamine exposure resulted in anxiolytic- and antidepressant-like responses 2 months a

74 hether insulin-sensitizing strategies induce anxiolytic- and/or antidepressant-like activities and to

75 sion and are allosterically modulated by the anxiolytic, anticonvulsant, and sedative-hypnotic benzod

76 sized within the brain and act as endogenous anxiolytic, anticonvulsant, hypnotic, and sedative agent

77 important classes of clinical agents (e.g., anxiolytics, anticonvulsants, and general anesthetics) t

78 piandrosterone (DHEA) is a neurosteroid with anxiolytic, antidepressant, and antiglucocorticoid prope

79 with RS67333, similar to fluoxetine, induced anxiolytic/antidepressant-like activity and stimulated a

80 ronic treatment with GR125487 prevented both anxiolytic/antidepressant-like and neurogenic effects of

81 Sedatives and anxiolytics, antidepressants, antipsychotics, lithium sa

82 o corticosteroids, opioids, benzodiazepines, anxiolytics, antidepressants, beta-blockers, anaesthetic

83 ed pronounced cannabinoid receptor-dependent anxiolytic, antiinflammatory, and analgesic effects in m

84 e US prescription fills for antidepressants, anxiolytics, antipsychotics, opioids, and antiepileptics

85 task for escape, the elevated plus maze for anxiolytic/anxiogenic effects, place preference conditio

86 etic BDZ, with clonazepam, an anticonvulsant/anxiolytic BDZ that activates CBRs selectively.

87 accompanied by improvements in cognitive and anxiolytic behavior and the normalization of changes in

88 ethanol produced lasting antidepressant and anxiolytic behaviours.

89 low-wave oscillations offer an ameliorating, anxiolytic benefit on these brain networks following sle

90 ecognition test but had no antidepressant or anxiolytic benefit.

91 pounds in animals with a history of sedative-anxiolytic/benzodiazepine self-administration.

92 (BNST) inhibitory microcircuit that silences anxiolytic BNST outputs to the ventral tegmental area an

93 ncome adults prescribed an antidepressant or anxiolytic by a primary care or non-MH professional and

94 )R-selective benzodiazepine site agonist and anxiolytic compound TP003 increases tonic currents and d

95 Many anxiolytic compounds (e.g. ethanol) can increase stresso

96 er and punisher value, pretreatment with the anxiolytic diazepam, and biological sex.

97 The effect of a subsedative, anxiolytic dose of diazepam (2 mg kg intraperitoneal) wa

98 epine-induced susceptibility to infection at anxiolytic doses in mice.

99 arallel in behaving animals and link them to anxiolytic drug action, novelty, and the metric for self

100 pproach-avoidance conflict tests in terms of anxiolytic drug action.

101 Buspirone is an anxiolytic drug and is a partial agonist for the seroton

102 Environmental concentrations of the anxiolytic drug oxazepam have been found to disrupt anti

103 ruder (HI) that are known to be sensitive to anxiolytic drug treatment.

104 vironmental novelty decreases slope, whereas anxiolytic drugs reduce intercept.

105 alidity mainly rests on the observation that anxiolytic drugs reduce rodent anxiety-like behavior.

106 a5-GABAARs may be suitable targets for novel anxiolytic drugs.

107 of treatment expectations to the efficacy of anxiolytic drugs.

108 nct from avoidance of danger, and reduced by anxiolytic drugs.

109 translational model for the investigation of anxiolytic drugs.

110 vity (e.g., voluntary wheel running)-induced anxiolytic effect and adult DG neurogenesis.

111 molecular underpinnings of the MitoQ-driven anxiolytic effect and found that MitoQ treatment alters

112 Scopolamine (800 microM) also had an anxiolytic effect in a group behavioural test, as it sig

113 JNJ-42165279 appears to elicit an anxiolytic effect in subjects with SAD although trough c

114 Moreover, exogenous NRG1 also produced an anxiolytic effect in the stressed mice.

115 receptors in the dBNST is necessary for the anxiolytic effect observed following optogenetic stimula

116 d activation of the rACC correlated with the anxiolytic effect of alprazolam (r(p) = .52; p = .04).

117 Following 3 weeks of wheel access, the anxiolytic effect of exercise was assessed using acousti

118 or and ongoing stress delays or prevents the anxiolytic effect of exercise without affecting exercise

119 impact of prior and concurrent stress on the anxiolytic effect of exercise.

120 re performed to estimate significance of the anxiolytic effect of lavender essential oil taken as sil

121 Importantly, the anxiolytic effect of ML297 was lost in mice lacking GIRK

122 Finally, we could show that the anxiolytic effect of NPS seen after i.c.v. or intra-PVN

123 rotein synthesis within the PVN prevents the anxiolytic effect of OXT in male rats.

124 eptide Y receptor 5 antagonist prevented the anxiolytic effect of OXT.

125 and that the AMY is a key substrate for the anxiolytic effect of PPARgamma.

126 ith the antagonist bicuculline, reverses the anxiolytic effect of running.

127 The anxiolytic effect of scopolamine was dose dependent and

128 The anxiolytic effect of social familiarity could be elicite

129 etermine whether intranasal OT has a general anxiolytic effect on the performance of rhesus monkeys t

130 ctivation of eEF2 within the PVN conveyed an anxiolytic effect supporting a role of OXT-induced eEF2

131 However, this aHipp-mediated anxiolytic effect was blocked by simultaneous pharmacolo

132 This anxiolytic effect was specific for high anxiety as MitoQ

133 ale, but not female, mice, thus producing an anxiolytic effect.

134 pe CT/T/C showed an opposing, dose-dependent anxiolytic effect.

135 r time in the open field test, suggesting an anxiolytic effect.

136 motor coordination deficits, and induces an anxiolytic effect.

137 n social behaviors are due to a more general anxiolytic effect.

138 in music preference, suggesting a potential anxiolytic effect.

139 downstream CeA--exerted an acute, reversible anxiolytic effect.

140 verexpression of Dnmt3a induced an opposite, anxiolytic, effect in wild-type mice.

141 estigations of individual moderators of OT's anxiolytic effects (i.e. sex, genetic factors, and early

142 in circuits are really responsible for their anxiolytic effects and how these regions interact.

143 intra-mPFC infusion of RS67333 produced fast anxiolytic effects and increased DRN 5-HT cell firing.

144 ed rapid and long-lasting antidepressant and anxiolytic effects and that these effects are associated

145 anism through which these agents exert their anxiolytic effects at a brain level in gSP.

146 receptors (5-HT(4)Rs) has been shown to have anxiolytic effects in a variety of animal models.

147 tivate FGF receptors have antidepressant and anxiolytic effects in animal models, FGF ligands have a

148 ctivity could mediate acute exercise-induced anxiolytic effects in regards to amygdala reactivity, an

149 Neuropeptide Y (NPY) produces anxiolytic effects in rodent models, and naturally occur

150 Oxytocin (OXT) is a nonapeptide that exerts anxiolytic effects in the brain.

151 mice beta-catenin mediates pro-resilient and anxiolytic effects in the nucleus accumbens, a key brain

152 eting of these mitochondrial pathways exerts anxiolytic effects in vivo.

153 Finally, anxiolytic effects induced by an acute systemic RS67333

154 Serotonin depletion prevented anxiolytic effects induced by mPFC infusion of RS67333.

155 nsmission as a key synaptic correlate of the anxiolytic effects of 2-AG augmentation.

156 Anxiolytic effects of an acute systemic administration (

157 Surprisingly the anxiolytic effects of mPFC infusion diazepam (1.5 mug/si

158 alpha4-nAChRs are necessary for the anxiolytic effects of nicotine in the elevated plus maze

159 inergic neurons decreased sensitivity to the anxiolytic effects of nicotine.

160 Anxiolytic effects of NPY are mediated in the CA1 region

161 induce protein synthesis, which mediates the anxiolytic effects of OXT within the PVN and suggests th

162 To provide evidence that anxiolytic effects of RS67333 recruited an mPFC-DRN neur

163 However, unlike fluoxetine, anxiolytic effects of RS67333 were already present after

164 brafish as a model organism for studying the anxiolytic effects of scopolamine, its mechanisms of act

165 ntagonism potentiates the antidepressant and anxiolytic effects of SSRIs.

166 FC completely blocked the antidepressant and anxiolytic effects of systemic ketamine in rodent models

167 ing that they had developed tolerance to the anxiolytic effects of the drug.

168 Moreover, RX-055 exerted site-specific anxiolytic effects on in situ photoactivation in the bra

169 Similar anxiolytic effects were observed with unilateral infusio

170 In addition, exercise has been shown to have anxiolytic effects, further confounding interpretation o

171 ultiple reports of DHEA's antidepressant and anxiolytic effects, no research to date has examined the

172 spectively, has not produced the anticipated anxiolytic effects, our data show that targeted interfer

173 ese findings demonstrate that BHB exerts its anxiolytic effects, possibly by inhibiting systemic TNF-

174 se CT equivalent has positively reinforcing, anxiolytic effects, suggesting a role in grooming and af

175 gmentation of therapeutic antidepressant and anxiolytic effects.

176 atory properties may have antidepressant and anxiolytic effects.

177 mechanism whereby activation of OXTRs exerts anxiolytic effects.

178 atching), suggesting the possibility of some anxiolytic effects.

179 ffects on social behaviors may be due to its anxiolytic effects.

180 upporting the conclusion that BNST-AL exerts anxiolytic effects.

181 the dorsal raphe nucleus (DRN) induced fast anxiolytic effects.

182 and had improved latency for its therapeutic anxiolytic effects.

183 e often used for their sedative/hypnotic and anxiolytic effects.

184 sults in the development of tolerance to the anxiolytic effects.

185 with irritable bowel syndrome (IBS) and have anxiolytic effects.

186 d RS67333 and diazepam mPFC infusion-induced anxiolytic effects.

187 uggests that cholinergic modulation may have anxiolytic effects.

188 n-induced inhibition of dopamine neurons and anxiolytic effects.

189 treatment exhibited both antidepressant and anxiolytic effects.

190 ts of amygdala manipulations be explained by anxiolytic effects?

191 The potential anxiety-reducing (anxiolytic) effects of scopolamine could have great clin

192 In light of the improved anxiolytic efficacy and benign side effects of NPS in et

193 n transporter (5-HTT) has antidepressant and anxiolytic efficacy in adulthood.

194 exposure regimen that did not compromise the anxiolytic efficacy of CDP in control mice, the results

195 exposure to the EPM completed abolishes the anxiolytic efficacy of chlordiazepoxide (CDP; 15 mg/kg)

196 In addition, OT acts as an anxiolytic factor and is released during stress.

197 Here, we report that anxiolytic FGIN-1-27 inhibits differentiation and pathog

198 in the rat BLA, ASIC1a has an inhibitory and anxiolytic function.

199 d of anxiety patients remain unresponsive to anxiolytics highlighting the need for more effective, me

200 DDIs between DAAs and antidepressants, anxiolytics, hypnotics, mood stabilizers, antipsychotics

201 Lef1 is required for the differentiation of anxiolytic hypothalamic neurons in zebrafish and mice, a

202 that 4 weeks of voluntary wheel running was anxiolytic in C57BL/6J mice and resulted in a shorter ti

203 Similar to humans, scopolamine acted as an anxiolytic in individual behavioural tests (novel approa

204 Further, exercise was not anxiolytic in stressed mice.

205 Here, we show that the most prescribed anxiolytic in Sweden (oxazepam) persists in its therapeu

206 of 5 mug of DA improved working memory, was anxiolytic in the plus maze, and increased pain sensitiv

207 rcumstances, rather than acting as a general anxiolytic, in a highly translatable nonhuman model, the

208 nterodorsal BNST-associated activity exerted anxiolytic influence for the same features.

209 reas our data do not provide evidence for an anxiolytic-like action of alpha3-GABAARs.

210 ce that modulation of alpha5-GABAARs elicits anxiolytic-like actions, whereas our data do not provide

211 VU0285683 had anxiolytic-like activity in two rodent models for anxiet

212 a broad antipsychotic-, antidepressant-, and anxiolytic-like activity, not eliciting motor impairment

213 5MPEPy also demonstrated antidepressant- and anxiolytic-like activity.

214 gh affinity value (Ki = 0.27 nM) and for its anxiolytic-like and ability to relieve neuropathic painf

215 GABAA receptor subtype ligands endowed with anxiolytic-like and antihyperalgesic action or enhancer

216 ological inhibition of GSK-3beta resulted in anxiolytic-like and pro-social behavior.

217 illation by enhancing its amplitude leads to anxiolytic-like behavior.

218 nthetic CXCR7 ligand is sufficient to induce anxiolytic-like behavior.

219 ective agonist, elicited antidepressant- and anxiolytic-like behavioral effects in wild-type mice, wi

220 pal CA1 region displayed antidepressant- and anxiolytic-like behaviors associated with widespread enh

221 S) exhibited spontaneous antidepressant- and anxiolytic-like behaviors.

222 RS 67333 was found to produce a paradoxical anxiolytic-like effect similar to that produced by the 5

223 further characterized and exhibited improved anxiolytic-like effects in a mouse marble burying assay

224 oid 2-arachidonoyl-sn-glycerol (2-AG), exert anxiolytic-like effects in rodent models via 2-AG-depend

225 tor of arousal and has been shown to produce anxiolytic-like effects in rodents.

226 ntion and induced marked antidepressive- and anxiolytic-like effects in socially isolated mice with r

227 generated behavioral profiles indicative of anxiolytic-like effects in the EZM, which was apparent f

228 WH133 (0.3, 1 and 3 mg/kg, IP) also produced anxiolytic-like effects in TMT-stressed rats, which were

229 mplicate the Y(5) receptor in the long-term, anxiolytic-like effects of NPY in the BLA, consistent wi

230 al striatum produced antidepressant-like and anxiolytic-like effects on FST and NSFT respectively.

231 HZ-166 (2) has been shown to have anxiolytic-like effects with reduced sedative/ataxic lia

232 ific effects of THC such as memory deficits, anxiolytic-like effects, and social interaction are unde

233 ed adiponectin expression and antidepressant/anxiolytic-like effects.

234 spectrum anti-stress and antidepressant- and anxiolytic-like efficacy in rodent behavioral paradigms.

235 The peptide hormone oxytocin (OXT) exhibits anxiolytic-like properties in animals and humans, but wh

236 ressant-like activities as well as potential anxiolytic-like properties.

237 in the SmartCube behavioral assay and showed anxiolytic-like signatures following daily dose administ

238 he Mecp2(-/y) respiratory phenotype and that anxiolytics may be effective.

239 Alprazolam was used to test whether anxiolytic medication diminished SI effects.

240 s a clinically available, non-benzodiazepine anxiolytic medication that acts on both serotonin and do

241 s a clinically available, non-benzodiazepine anxiolytic medication that acts on serotonin and dopamin

242 nts had increased risk of antidepressant and anxiolytic medication use, while patients with mild AD o

243 ents with mild AD only had increased risk of anxiolytic medication use.

244 n that was unrelated to antipsychotic and/or anxiolytic medication.

245 erated because of patient anxiety, yet acute anxiolytic medications typically cause sedation and impa

246 ety to the point that intravenous anesthetic/anxiolytic medications were discontinued and cognitive t

247 s received much attention as a prosocial and anxiolytic neuropeptide.

248 europeptide Y (NPY) is a putative endogenous anxiolytic neurotransmitter that adaptively regulates re

249 ctively prevented with antipsychotic but not anxiolytic or antidepressant compounds.

250 ale) to have cerebrovascular disease and use anxiolytic or antipsychotic drugs.

251 a3 GABA(A)Rs present an important target for anxiolytic or fear-reducing compounds.

252 neous colitis and, in stressed mice, induced anxiolytic or fear-reducing effects as measured on the e

253 mans, suggesting co-regulation of 2 parallel anxiolytic pathways in primates.

254 ential for this system as a novel target for anxiolytic pharmacotherapy.

255 epines (BZDs) represent the gold standard of anxiolytic pharmacotherapy; however, their clinical bene

256 orebrain in fb-A2AR KO mice also produced an anxiolytic phenotype in both the elevated plus maze and

257 ng plasma corticosterone did not reverse the anxiolytic phenotype of Sim1CrhKO mice.

258 c hormone, but surprisingly, have a profound anxiolytic phenotype when evaluated using multiple stres

259 Rit2 knockdown (Rit2-KD), mice displayed an anxiolytic phenotype, with no change in baseline locomot

260 ocomotion, reduced sociability, and a strong anxiolytic phenotype.

261 GABAergic projections produced rewarding and anxiolytic phenotypes, which were also recapitulated by

262 hat global EIF2 signaling has antidepressant/anxiolytic potential.

263 er health care visits and antidepressant and anxiolytic prescriptions in 2015 as a function of gender

264 order health care visits, antidepressant and anxiolytic prescriptions, and hospitalization after a su

265 tartle response, which is consistent with an anxiolytic profile.

266 ent of anxiety disorders due to their potent anxiolytic profile.

267 nociceptin may underlie its anti-alcohol and anxiolytic properties and identify the nociceptin recept

268 Neuropeptide Y (NPY) has robust anxiolytic properties and is reduced in patients with an

269 activates eEF2 also in neurons to exert its anxiolytic properties in the PVN, we performed in vivo a

270 E STATEMENT: Neuropeptide Y (NPY) has robust anxiolytic properties, and its levels are reduced in pat

271 gamma-aminobutyric acid type A receptor with anxiolytic properties.

272 e fear extinction learning may explain their anxiolytic properties.

273 dered beneficial to mental health due to its anxiolytic, prosocial and antistress effects, but eviden

274 training administration of DCS abolished the anxiolytic response to CDP challenge.

275 The current study demonstrates a robust anxiolytic response to cingulum bundle stimulation in 3

276 ynaptic GABAARs could mediate the maintained anxiolytic response to EtOH in dependent individuals, ra

277 ight constitute a strategy to produce a fast anxiolytic response.

278 tment in adulthood evokes antidepressant and anxiolytic responses.

279 es rapid and long-lasting antidepressant and anxiolytic responses.

280 s in modulating anxiety, establish separable anxiolytic roles for different anterodorsal BNST project

281 The anxiolytic, sedating, and myorelaxant effects of BZDs ar

282 a neurons is important for identifying novel anxiolytic targets.

283 s a more sensitive measure of the effects of anxiolytics than traditional spatiotemporal indices.

284 AH inhibitors may represent a novel class of anxiolytics that specifically target stress-induced anxi

285 elp establish exercise training as a form of anxiolytic therapy towards clinical applications.

286 nhibition of this system may be an effective anxiolytic therapy.

287 mplicating central baroreflex mechanisms for anxiolytic treatment targets.

288 d PTSD and women receiving antidepressant or anxiolytic treatment would be more likely to experience

289 threat-induced anxiety are reversed by acute anxiolytic treatment.

290 om punishment that could be ameliorated with anxiolytic treatment.

291 Currently available anxiolytic treatments are limited by side effects, inclu

292 fear vigilance is similar to that seen with anxiolytic treatments in the same cognitive paradigm.

293 ide key neural modulation targets for future anxiolytic treatments.

294 may be a target for the development of novel anxiolytic treatments.

295 ment were treatment naivety, anxiety, use of anxiolytics, use of antidepressants, use of opioids, rib

296 wn to have procognitive, antipsychotic-like, anxiolytic, weight-reducing, glucose-lowering, and wake-

297 red to psoriasis patients, except for use of anxiolytics, which was higher in severe AD.

298 potential as a faster acting antidepressant/anxiolytic with reduced side-effect burden.

299 ation of benzodiazepines, Z-drugs, and other anxiolytics with incident dementia in patients with affe

300 TAT-CBD3 was mildly anxiolytic without affecting memory retrieval, sensorimo